CB41892-25 - 0x00000000000062A4
Healthy Males & Females
Alloy
* Stipend may pay up to reflected amount.
Start Date:
November 20, 2024 - 1:30pm
End Date:
December 11, 2024 - 8:00am
Study Details
Study Number: CB41892
Group Number: 25
Study Requirement: Healthy Normal Male and Female
Stipend: up to $9,500.00
Study Criteria
Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat multiple sclerosis.
Route of Administration: Oral
Blood Draws: 37
Study Schedule
Schedule Type: Long Term
Study Length: 17 Night Stay & 1 Return
Screening Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 11/14/2024 |
| Tuesday | 11/19/2024 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 11/14/2024 |
| Tuesday | 11/19/2024 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Wednesday | 11/20/2024 1:30:00 PM | Saturday | 12/7/2024 8:30:00 AM | 1 | Lincoln |
| Return | Wednesday | 12/11/2024 6:30:00 AM | Wednesday | 12/11/2024 8:00:00 AM | 1 | Lincoln |
